Research Diagnosis Related Groups (DRG) level LOS quality outcomes for AllianceHealth Midwest located at 2825 Parklawn Dr, Midwest City, OK, 73110 & includes data from NPIs 1093169377, 1043805732, 1730128836, 1417998691, 1700471497
Dexur analyzed Q1 2019 (January to March 2019) Medicare claims data to benchmark length of stay (LOS) outcomes for AllianceHealth Midwest compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 689 | 624 | ||||||||||
| Surgical | 140 | 128 | ||||||||||
| Non Surgical | 549 | 496 | ||||||||||
| Cardiovascular | 123 | 108 | ||||||||||
| General Medicine | 107 | 91 | ||||||||||
| Psychiatry & Mental Disorders | 107 | 102 | ||||||||||
| Pulmonology | 90 | 80 | ||||||||||
| Gastroenterology & Endocrinology | 62 | 57 | ||||||||||
| Urology | 49 | 45 | ||||||||||
| Orthopedics | 49 | 46 | ||||||||||
| General Surgery | 36 | 34 | ||||||||||
| Neurology | 33 | 30 | ||||||||||
| Oncology & Hematology | 15 | 13 |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| Acute Myocardial Infarction |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jan 2019 to Mar 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |